Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
3don MSN
Some VA therapists and patients say their treatment sessions are being limited, raising alarm
An edge comes to Michael’s voice when he speaks about his time serving in Afghanistan and his struggles living with post-traumatic stress disorder.
FOCUS is a randomized, double-blind, placebo-controlled crossover pilot study evaluating Tonix’s investigational intranasal potentiated oxytocin ...
The Chosun Ilbo on MSN
Parent's Malicious Complaints Over Smoking Discipline Prompt Teacher Protection Calls
A parent of a high school student has been reported for filing complaints accusing a teacher of human rights violations and child abuse after the teacher disciplined the student for smoking. On the ...
Topline results were announced from a phase 3 trial evaluating BNC210 in patients with social anxiety disorder.
PRESSADVANTAGE – Moment of Clarity has published a new resource titled “Using Ketamine for Anxiety and PTSD Treatment“, now ...
The program in question is Neuphoria’s BNC210, also known as soclenicant, an α7 nicotinic receptor negative alteration ...
The Karnataka Tele-MANAS cell, part of the National Tele Mental Health Programme, has seen calls multiply nearly 60-fold ...
Veterans with vs without SLE or RA had higher incidences of adverse pregnancy outcomes, including nonlive birth.
Clinical Trials Arena on MSN
Neuphoria scraps social anxiety hopeful after Phase III miss
Analysts from William Blair and GlobalData critiqued the trial design for social anxiety disorder, though the latter notes ...
Neuphoria added it has an ongoing partnership with Merck & Co. under which MK-1167 is currently being evaluated in a Merck-led Phase 2 trial in Alzheimer's disease. Through the partnership, Neuphoria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback